MAIA Biotechnology Inc.

AMEX: MAIA · Real-Time Price · USD
1.57
0.01 (0.64%)
At close: Aug 15, 2025, 3:59 PM
1.55
-1.27%
After-hours: Aug 15, 2025, 05:22 PM EDT

MAIA Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Mar 31, 2021
Cash & Equivalents
10.14M 10.86M 9.6M 8.69M 11.58M 8.27M 7.15M 6.1M 9.15M 7.59M 10.95M 14.06M 8.15M 10.29M 10.57M 10.95M -663.46K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.33M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 320K n/a
Other Long-Term Assets
2.8K 2.8K 2.8K 2.8K 2.8K 16.04K 2.8K 367.94K 492.45K 740.49K 214K 2.8K 1.15M 916.48K 654.7K 520.65K -663.46K
Receivables
82.27K 78.08K 77.35K 53.61K 177.69K 155.97K 144.68K 114.43K 386.82K 348.38K 302.79K n/a 203.16K n/a 43.67K n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -255.31K -203.16K n/a n/a n/a n/a
Other Current Assets
816.26K 920.47K 473.83K 495.65K 259.73K 272.58K 268.68K 414.12K 243.33K 398.87K 554.32K n/a n/a n/a n/a 0.00 n/a
Total Current Assets
11.04M 11.86M 10.15M 9.24M 12.02M 8.7M 7.56M 6.63M 9.78M 8.33M 11.81M 14.78M 8.61M 10.53M 10.67M 11.04M 663.46K
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
2.8K 2.8K 2.8K 2.8K 2.8K 16.04K 2.8K 367.94K 492.45K 740.49K 214K 2.8K 1.15M 916.48K 654.7K 840.65K -663.46K
Total Assets
11.05M 11.86M 10.16M 9.24M 12.02M 8.72M 7.57M 7M 10.27M 9.07M 12.02M 14.78M 9.76M 11.44M 11.33M 11.88M n/a
Account Payables
1.72M 1.84M 1.51M 1.15M 1.26M 1.87M 1.64M 1.23M 1.55M 1.13M 1.17M 1.02M 1.04M 895.11K 960.4K 497.25K n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 111.27K -497.25K n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 48.61K n/a
Other Current Liabilities
2.73M 1.23M 941.1K 2.46M 1.39M 1.43M n/a n/a 0.00 1.23M n/a n/a 1.16M n/a 689.57K 655.58K n/a
Total Current Liabilities
5.04M 5.06M 3.83M 3.61M 3.51M 4.91M 4.94M 4.15M 3.27M 3.77M 3.27M 2.46M 3.1M 2.43M 2.15M 1.31M n/a
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 13.89K n/a
Other Long-Term Liabilities
2.13M 1.86M 2.69M 4.02M 5.35M 9.57M 2.15M 103.41K 121.6K 224.4K 245.34K -215.71K n/a n/a n/a n/a n/a
Total Long-Term Liabilities
2.13M 1.86M 2.69M 4.02M 5.35M 9.57M 2.15M 103.41K 121.6K 224.4K 245.34K 1.02M 1.04M 895.11K n/a 13.89K n/a
Total Liabilities
7.17M 6.92M 6.52M 7.62M 8.86M 14.48M 7.09M 4.25M 3.39M 3.99M 3.51M 2.46M 3.1M 2.43M 2.15M 1.33M n/a
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 215.71K n/a n/a n/a 62.5K n/a
Common Stock
3.18K 2.96K 2.62K 2.4K 2.37K 2.06K 1.7K 1.38K 1.36K 1.1K 1.1K 1.09K 842.00 794.00 758.00 725.00 n/a
Retained Earnings
-97.1M -91.75M -87.23M -83.66M -80.93M -72.05M -63.98M -57.72M -52.85M -48.32M -44.21M -39.09M -35.16M -31.85M -28.44M -25.55M n/a
Comprehensive Income
-30.03K -38.16K -30.61K -11.7K -22.18K -30.05K -16.26K -43.77K -25.91K -25.27K -15.97K -51.65K -4.14K 1.72K n/a -320K -3.34M
Shareholders Equity
3.88M 4.94M 3.63M 1.62M 3.16M -5.76M 477.51K 2.75M 6.87M 5.08M 8.51M 12.33M 6.66M 9.01M 9.18M 10.55M -1.62M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 320K 1.33M